Ventas, Inc.
VTR Real Estate Reit Healthcare Facilities
Ventas, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, up 18.5% from fiscal 2024. In the quarter to June 2026, revenue grew 21.7%, EPS fell 6.67%, free cash flow grew 13.6% and total debt fell 2.82%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for five; insiders bought in the last twelve months.
Follow VTR
Ventas, Inc. (VTR) EV/Sales
As of 9 October 2026, Ventas, Inc. (VTR) trades at a EV/Sales of 8.2×. Over the past ten years it has ranged from 4.7× (March 2020) to 14.0× (April 2015); the current reading is higher than 38% of that period. That is in line with the Reit Healthcare Facilities industry median of 8.3× and above the Real Estate sector median of 7.6×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 8.1× | 8.77% |
| FY2024 | 7.5× | 1.14% |
| FY2023 | 7.4× | 0.89% |
| FY2022 | 7.3× | (10.67%) |
| FY2021 | 8.2× | 4.63% |
| FY2020 | 7.8× | (8.40%) |
| FY2019 | 8.6× | 1.85% |
| FY2018 | 8.4× | (7.08%) |
| FY2017 | 9.0× | (3.22%) |
| FY2016 | 9.3× | 3.34% |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 8.7× | 3.85% |
| Mar 2026 | 8.4× | 2.79% |
| Dec 2025 | 8.1× | 2.09% |
| Sep 2025 | 8.0× | 3.11% |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| AHR American Healthcare REIT, Inc. compare | 4.4× |
| HR Healthcare Realty Trust Incorporated compare | 5.2× |
| DOC Healthpeak Properties, Inc. compare | 7.2× |
| VTR Ventas, Inc. | 8.2× |
| SBRA Sabra Healthcare REIT, Inc. compare | 8.3× |
| NHI National Health Investors, Inc. compare | 10.1× |
| OHI Omega Healthcare Investors, Inc. compare | 10.2× |
| WELL Welltower Inc. compare | 13.8× |
| CTRE CareTrust REIT, Inc. compare | 16.8× |
| Reit Healthcare Facilities industry median | 8.3× |
| Real Estate sector median | 7.6× |
| Market median | 2.2× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)
More on VTR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- The full statement